Brent Rupnow
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, Metabolomics and Mass Spectrometry Studies, Radiopharmaceutical Chemistry and Applications, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2011)275 cited
- → Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor(2005)203 cited
- Modulation of c-Myc activity and apoptosis in vivo.(1996)
- → The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy(1999)87 cited
- Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.(1998)
- → Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors(2020)78 cited
- → Fundulus heteroclitus gonadotropins. 3. Cloning and sequencing of gonadotropic hormone (GTH) I and II β-subunits using the polymerase chain reaction(1992)70 cited
- → Association of BCL-2 with membrane hyperpolarization and radioresistance(1996)43 cited
- → Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University(2001)41 cited
- → p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts(1998)33 cited